Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Deferoxamine followed by cyclophosphamide, etoposide, carboplatin, thiotepa, induction regimen in advanced neuroblastoma: preliminary results. Italian Neuroblastoma Cooperative Group.
Donfrancesco A, De Bernardi B, Carli M, Mancini A, Nigro M, De Sio L, Casale F, Bagnulo S, Helson L, Deb G. Donfrancesco A, et al. Among authors: de bernardi b, de sio l. Eur J Cancer. 1995;31A(4):612-5. doi: 10.1016/0959-8049(95)00068-t. Eur J Cancer. 1995. PMID: 7576980 Clinical Trial.
Role of deferoxamine in tumor therapy.
Donfrancesco A, Deb G, De Sio L, Cozza R, Castellano A. Donfrancesco A, et al. Among authors: de sio l. Acta Haematol. 1996;95(1):66-9. doi: 10.1159/000203951. Acta Haematol. 1996. PMID: 8604589 Review.
Ifosfamide/carboplatin/etoposide (ICE) as front-line, topotecan/cyclophosphamide as second-line and oral temozolomide as third-line treatment for advanced neuroblastoma over one year of age.
Donfrancesco A, Jenkner A, Castellano A, Ilari I, Milano GM, De Sio L, Cozza R, Fidani P, Deb G, De Laurentis C, Inserra A, Dominici C. Donfrancesco A, et al. Among authors: de laurentis c, de sio l. Acta Paediatr Suppl. 2004 May;93(445):6-11. doi: 10.1111/j.1651-2227.2004.tb03048.x. Acta Paediatr Suppl. 2004. PMID: 15176712 Clinical Trial.
High histologic and overall response to dose intensification of ifosfamide, carboplatin, and etoposide with cyclophosphamide, doxorubicin, and vincristine in patients with high-risk Ewing sarcoma family tumors: the Bambino Gesù Children's Hospital experience.
Milano GM, Cozza R, Ilari I, De Sio L, Boldrini R, Jenkner A, De Ioris M, Inserra A, Dominici C, Donfrancesco A. Milano GM, et al. Among authors: de ioris m, de sio l. Cancer. 2006 Apr 15;106(8):1838-45. doi: 10.1002/cncr.21780. Cancer. 2006. PMID: 16532434 Free article. Clinical Trial.
A multimodal strategy based on surgery, radiotherapy, ICE regimen and high dose chemotherapy in atypical teratoid/rhabdoid tumours: a single institution experience.
Fidani P, De Ioris MA, Serra A, De Sio L, Ilari I, Cozza R, Boldrini R, Milano GM, Garrè ML, Donfrancesco A. Fidani P, et al. Among authors: de ioris ma, de sio l. J Neurooncol. 2009 Apr;92(2):177-83. doi: 10.1007/s11060-008-9750-y. Epub 2008 Nov 29. J Neurooncol. 2009. PMID: 19048188 Clinical Trial.
Sequential high-dose chemotherapy for children with metastatic rhabdomyosarcoma.
Bisogno G, Ferrari A, Prete A, Messina C, Basso E, Cecchetto G, Indolfi P, Scarzello G, D'Angelo P, De Sio L, Di Cataldo A, Carli M. Bisogno G, et al. Among authors: de sio l. Eur J Cancer. 2009 Nov;45(17):3035-41. doi: 10.1016/j.ejca.2009.08.019. Epub 2009 Sep 25. Eur J Cancer. 2009. PMID: 19783136 Clinical Trial.
99 results